Repositorio Dspace

Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry

Mostrar el registro sencillo del ítem

dc.contributor.author Mena-Vázquez, Natalia
dc.contributor.author Fernández-Nebro, Antonio
dc.contributor.author Pego-Reigosa, José-María
dc.contributor.author Galindo, María
dc.contributor.author Melissa-Anzola, Ana
dc.contributor.author Uriarte-Isacelay, Esther
dc.contributor.author Olive-Marques, Alejandro
dc.contributor.author Aurrecoechea, Elena
dc.contributor.author Freire, Mercedes
dc.contributor.author Tomero, Eva
dc.contributor.author García-Villanueva, María-Jesús
dc.contributor.author Stoye, Claudia
dc.contributor.author Salas-Heredia, Esteban
dc.contributor.author Bernal-Vidal, José-Antonio
dc.contributor.author Salgado, Eva
dc.contributor.author Blanco, Ricardo
dc.contributor.author Javier-Novoa, Francisco
dc.contributor.author Ibanez-Barcelo, Mónica
dc.contributor.author Torrente-Segarra, Vicente
dc.contributor.author Narvaez, Javier
dc.contributor.author Calvet, Joan
dc.contributor.author Moriano-Morales, Clara
dc.contributor.author Vázquez-Rodríguez, Tomás-Ramón
dc.contributor.author García-de-la-Pena, Paloma
dc.contributor.author Bohórquez, Cristina
dc.contributor.author Andreu-Sánchez, José-Luis
dc.contributor.author Cobo-Ibanez, Tatiana
dc.contributor.author Bonilla, Gema
dc.contributor.author Lozano-Rivas, Nuria
dc.contributor.author Montilla, Carlos
dc.contributor.author Javier-Toyos, Francisco
dc.contributor.author Marenco-De-la-Fuente, José-Luis
dc.contributor.author Exposito, Lorena
dc.contributor.author Ruiz-Lucea, María-Esther
dc.contributor.author Vals, Elia
dc.contributor.author Manero-Ruiz, Javier
dc.contributor.author Bernal-Vidal, José-Antonio
dc.contributor.author Rua-Figueroa, Inigo
dc.date.accessioned 2025-05-09T10:02:31Z
dc.date.available 2025-05-09T10:02:31Z
dc.date.issued 2020-08
dc.identifier.citation Mena-Vázquez N, Fernández-Nebro A, Pego-Reigosa JM, Galindo M, Melissa-Anzola A, Uriarte-Isacelay E, et al. Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry. Rheumatology (Oxford). 1 de agosto de 2020;59(8):2043-51.
dc.identifier.issn 1462-0324
dc.identifier.uri https://sms.carm.es/ricsmur/handle/123456789/18939
dc.description.abstract OBJECTIVES: This article estimates the frequency of polyautoimmunity and associated factors in a large retrospective cohort of patients with SLE. METHODS: RELESSER (Spanish Society of Rheumatology Lupus Registry) is a nationwide multicentre, hospital-based registry of SLE patients. This is a cross-sectional study. The main variable was polyautoimmunity, which was defined as the co-occurrence of SLE and another autoimmune disease, such as autoimmune thyroiditis, RA, scleroderma, inflammatory myopathy and MCTD. We also recorded the presence of multiple autoimmune syndrome, secondary SS, secondary APS and a family history of autoimmune disease. Multiple logistic regression analysis was performed to investigate possible risk factors for polyautoimmunity. RESULTS: Of the 3679 patients who fulfilled the criteria for SLE, 502 (13.6%) had polyautoimmunity. The most frequent types were autoimmune thyroiditis (7.9%), other systemic autoimmune diseases (6.2%), secondary SS (14.1%) and secondary APS (13.7%). Multiple autoimmune syndrome accounted for 10.2% of all cases of polyautoimmunity. A family history was recorded in 11.8%. According to the multivariate analysis, the factors associated with polyautoimmunity were female sex [odds ratio (95% CI), 1.72 (1.07, 2.72)], RP [1.63 (1.29, 2.05)], interstitial lung disease [3.35 (1.84, 6.01)], Jaccoud arthropathy [1.92 (1.40, 2.63)], anti-Ro/SSA and/or anti-La/SSB autoantibodies [2.03 (1.55, 2.67)], anti-RNP antibodies [1.48 (1.16, 1.90)], MTX [1.67 (1.26, 2.18)] and antimalarial drugs [0.50 (0.38, 0.67)]. CONCLUSION: Patients with SLE frequently present polyautoimmunity. We observed clinical and analytical characteristics associated with polyautoimmunity. Our finding that antimalarial drugs protected against polyautoimmunity should be verified in future studies.
dc.language.iso eng
dc.publisher OXFORD UNIV PRESS
dc.rights Atribución-NoComercial-SinDerivadas 4.0 España
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es *
dc.subject.mesh Adult
dc.subject.mesh Antirheumatic Agents/administration & dosage/therapeutic use
dc.subject.mesh Autoimmune Diseases/complications/immunology
dc.subject.mesh Autoimmunity/drug effects
dc.subject.mesh Cross-Sectional Studies
dc.subject.mesh Female
dc.subject.mesh Humans
dc.subject.mesh Hydroxychloroquine/administration & dosage/therapeutic use
dc.subject.mesh Lupus Erythematosus, Systemic/complications/drug therapy/immunology
dc.subject.mesh Male
dc.subject.mesh Middle Aged
dc.subject.mesh Registries
dc.subject.mesh Young Adult
dc.title Hydroxychloroquine is associated with a lower risk of polyautoimmunity: data from the RELESSER Registry
dc.type info:eu-repo/semantics/article
dc.identifier.pmid 31808534
dc.relation.publisherversion https://dx.doi.org/10.1093/rheumatology/kez562
dc.type.version info:eu-repo/semantics/publishedVersion
dc.identifier.doi 10.1093/rheumatology/kez562
dc.journal.title Rheumatology (Oxford, England)
dc.identifier.essn 1462-0332


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-SinDerivadas 4.0 España Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución-NoComercial-SinDerivadas 4.0 España

Buscar en DSpace


Búsqueda avanzada

Listar

Mi cuenta